Watch our latest webinar: Who can you trust? A pharma leader’s guide to vetting AI for insights
View Now
Product manager
Our thinking
Insights, strategy, and perspectives from the Day One team
Most insight leaders can now see the strategic potential of AI. They understand where it could help them with faster sense-making, broader exploration, and decisions made with greater confidence when time is short.
AI only matters in market research when it improves decisions, shapes investment, and increases the odds of market success.
Most insight leaders can now see the strategic potential of AI. They understand where it could help them with faster sense-making, broader exploration, and decisions made with greater confidence when time is short.
For years, the agency model has worked in the same linear way. A client has a question. They issue a brief. The agency runs a project. Weeks later, the client receives a report outlining the insights and some recommendations. The real work then begins, as teams take time to interpret the findings, align internally and decide what to do.
InsightBrain gives commercial leaders the signals and direction to deliver stronger launches, defend share, and stay ahead of the competition.
Insight-led growth means starting with the question, not the product. This article explores the strategic implications and practical steps you can take to apply these ideas in your own organisation.
Pharma doesn’t have an insight problem – it has an operating model problem. Despite unprecedented investment in data, research and content development, outcomes continue to disappoint. 77% of pharma content never reaches its intended audience. Half of launches miss expectations, and one in four delivers less than half its forecast.
